Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Apr;24(3):250–258. doi: 10.1136/jcp.24.3.250

An assessment of platelet aggregation induced by 5-hydroxytryptamine

Part I After pre-incubation with 5-hydroxytryptamine and reserpine

Barbara P Hilton 1, J N Cumings 1
PMCID: PMC476964  PMID: 5573439

Abstract

A method of expressing platelet aggregation response after incubation relative to the response before incubation has been used in preference to using direct measurements, and some reasons are given for this choice.

The effect of pre-incubating human platelets with reserpine has been compared with the effect of pre-incubation with 5-hydroxytryptamine (5HT). Reserpine inhibited 5HT-induced aggregation more slowly than 5HT and on this basis their actions could be distinguished.

It was found that the aggregation response of human platelets to 5HT without pre-incubation (R) is inversely proportional to the natural 5HT content of whole blood, and an explanation has been suggested.

A decrease in the aggregation response of human platelets to 5HT without pre-incubation (R) with increasing age has been noted, and is commented upon with reference to the release of amines from blood platelets.

Platelets in plasma obtained from control subjects and incubated with methysergide and from migrainous patients taking methysergide both have reduced aggregation responses to 5HT.

Platelets incubated with clonidine (St155) do not have reduced aggregation responses. A potentiating effect was noted after 20 minutes' incubation, but platelets from migraine patients taking St155 behaved normally.

Tyramine affected the response of platelets to 5HT, giving results similar to those reported for reserpine.

The differences between the aggregation responses to 5HT of platelets from migraine patients and normal control subjects are discussed.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHCROFT G. W., CRAWFORD T. B., BINNS J. K., MACDOUGALL E. J. ESTIMATION OF 5-HYDROXYTRYPTAMINE IN HUMAN BLOOD. Clin Chim Acta. 1964 Apr;9:364–369. doi: 10.1016/0009-8981(64)90027-0. [DOI] [PubMed] [Google Scholar]
  2. BARTHOLINI G., PLETSCHER A., BRUDERER H. DECOMPOSITION OF DILUTE HYDROGEN PEROXIDE IN ALKALINE SOLUTIONS. Nature. 1964 Sep 19;203:1281–1283. doi: 10.1038/2031281b0. [DOI] [PubMed] [Google Scholar]
  3. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  4. Bartholini G., Pletscher A. Two types of 5-hydroxytryptamine release from isolated blood platelets. Experientia. 1964 Jul 15;20(7):376–378. doi: 10.1007/BF02147970. [DOI] [PubMed] [Google Scholar]
  5. Baumgartner H. R. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets. J Physiol. 1969 Apr;201(2):409–423. doi: 10.1113/jphysiol.1969.sp008763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baumgartner H. R., Born G. V. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968 Apr 13;218(5137):137–141. doi: 10.1038/218137a0. [DOI] [PubMed] [Google Scholar]
  7. Baumgartner H. R., Born G. V. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. J Physiol. 1969 Apr;201(2):397–408. doi: 10.1113/jphysiol.1969.sp008762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CURRAN D. A., LANCE J. W. CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE. J Neurol Neurosurg Psychiatry. 1964 Oct;27:463–469. doi: 10.1136/jnnp.27.5.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  10. Curzon G., Barrie M., Wilkinson M. I. Relationships between headache and amine changes after administration of reserpine to migrainous patients. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):555–561. doi: 10.1136/jnnp.32.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GRAHAM J. R. METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS. N Engl J Med. 1964 Jan 9;270:67–72. doi: 10.1056/NEJM196401092700202. [DOI] [PubMed] [Google Scholar]
  12. HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HUMPHREY J. H., JAQUES R. The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species. J Physiol. 1954 May 28;124(2):305–310. doi: 10.1113/jphysiol.1954.sp005109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kloeze J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Biochim Biophys Acta. 1969 Oct 28;187(3):285–292. doi: 10.1016/0005-2760(69)90001-0. [DOI] [PubMed] [Google Scholar]
  15. Lance J. W., Anthony M., Somerville B. Comparative trial of serotonin antagonists in the management of migraine. Br Med J. 1970 May 9;2(5705):327–330. doi: 10.1136/bmj.2.5705.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MCLEAN J., NICHOLSON A., HERTLER D. AMINE TRANSPORT AND STORAGE IN RABBIT PLATELETS. Life Sci. 1963 Sep;9:683–690. doi: 10.1016/0024-3205(63)90155-3. [DOI] [PubMed] [Google Scholar]
  17. O'BRIEN J. R. A COMPARISON OF PLATELET AGGREGATION PRODUCED BY SEVEN COMPOUNDS AND A COMPARISON OF THEIR INHIBITORS. J Clin Pathol. 1964 May;17:275–281. doi: 10.1136/jcp.17.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'brien J. R. Platelet aggregation: Part I Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J Clin Pathol. 1962 Sep;15(5):446–452. doi: 10.1136/jcp.15.5.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother. 1968 Jan;32(1):1–16. doi: 10.1111/j.1476-5381.1968.tb00423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wilkinson M. Clonidine for migraine. Lancet. 1969 Aug 23;2(7617):430–430. doi: 10.1016/s0140-6736(69)90131-7. [DOI] [PubMed] [Google Scholar]
  21. Zaimis E., Hanington E. A possible pharmacological approach to migraine. Lancet. 1969 Aug 9;2(7615):298–300. doi: 10.1016/s0140-6736(69)90058-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES